Crestline Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-45,106
Closed -$5.37M 836
2024
Q3
$5.37M Buy
+45,106
New +$5.37M 0.28% 97